insights

by Shiri Habib Valdhorn

Medical device start-up superDimension has raised $24.8 million, to reach a total of over $100 million raised since its establishment 15 years ago. According to IVC, the company has raised $109.4 million, including the current round. The company has developed minimally-invasive devices that enable the diagnosis and potentially the treatment of distal lung disease. A majority of the current funding, $15 million, is from a credit line from Oxford Finance, a US financial institution that specializes in life sciences funding. The company also raised $9.8 million from existing investors, which include Medica , Oxford Bioscience Parters, OrbiMed Advisors LLC, and Pitango Venture Capital. superDimension’s technology was originally developed for the toy industry – navigation for toy planes – but subsequently the firm decided to focus on the medical device market. http://www.globes.co.il/serveen/globes/docview.asp?did=1000587915&fid=1725

by Shiri Habib-Valdhorn

TechnoPlus Ventures Ltd.  portfolio company RapiDx Ltd. is preparing for clinical trials of its self-applied blood test development device ahead of a planned launch in the US and Europe in 2012. The Tel Aviv-based company is seeking to raise $4.2 million from venture capital funds and angel investors. The company has raised less than $1 million to date. RapiDx was founded byNili Tamir. The company developed a disposable device for quick blood tests for early detection of diseases and complications from AIDS to high cholesterol. The device is designed for ease-of-use without the need for professional intervention. http://www.globes.co.il/serveen/globes/docview.asp?did=1000580869&fid=1725